Germany· DE-A57-e1c93b32f84a6992
Pancuroniumbromid Inresa
A pancuronium product containing pancuronium bromide, registered in Germany by Inresa Arzneimittel Gmbh. The same ATC class is registered in 5 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Pancuronium is registered in 5 of 19 countries.
Countries holding a registration under ATC M03AC01 (pancuronium), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Pancuronium · ATC M03AC01
5 / 19 countries
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Pancuronium Bromide
- Manufacturer
- Inresa Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- M03AC01
- ATC class
- Pancuronium
- Defined daily dose
- 6.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
108 interactions on record for pancuronium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pancuronium · interactions on record
108 records
- 12 severe
- 62 moderate
- 4 minor
- 30 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pancuronium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPancuronium bromide 4mg/2ml solution for injection ampoulesAlliance Healthcare (Distribution) Ltd
- NorwayPancuronium
- PolandPancuronium InresaDelfarma Sp. z o.o.
- FinlandPavulonN.V. Organon
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Poland · Pancuronium Jelfa
- Portugal · Brometo De Pancurónio Hikma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1dc1676-7f72-48b4-8d7b-21209862ed6c GET /v1/drugs/d1dc1676-7f72-48b4-8d7b-21209862ed6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Pancuronium Bromide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about pancuronium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.